ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,477Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 5176

$2.68M Total Retail Price of All Prescriptions

Rank: 21 out of 5176

420 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 420 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 420 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 25,703 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

57% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$101 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

63 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 1,271 1,236 1 16
CRESTOR 993 973 2 15
AMLODIPINE BESYLATE 793 767 3 2
METOPROLOL TARTRATE 753 698 4 6
LOVAZA 642 629 5 43
ZOLPIDEM TARTRATE 610 595 6 17
PLAVIX 479 475 7 29
METOPROLOL SUCCINATE 466 449 8 11
LIDODERM 454 454 9 59
CREON 422 405 10 111
FUROSEMIDE 393 375 11 8
SYNTHROID 375 365 12 33
METFORMIN HCL ER 370 345 13 57
DIOVAN HCT 366 354 14 39
DIOVAN 363 363 15 19
CHLORHEXIDINE GLUCONATE 316 316 16 202
VOLTAREN 311 305 17 97
MECLIZINE HCL 307 307 18 81
LISINOPRIL 294 282 19 5
SIMVASTATIN 291 285 20 1
BENICAR HCT 288 271 21 110
CARVEDILOL 286 286 22 24
AMLODIPINE BESYLATE-BENAZEPRIL 285 285 23 55
SINGULAIR 282 282 24 62
TAMSULOSIN HCL 274 274 25 20
CELEBREX 269 256 26 80
BENICAR 266 244 27 100
ATORVASTATIN CALCIUM 259 255 28 9
LIPITOR 248 238 29 51
ATENOLOL 227 227 30 12
FLUTICASONE PROPIONATE 209 206 31 38
PROCTOZONE-HC 196 189 32 171
NASONEX 190 190 33 178
JANUVIA 187 178 34 25
MELOXICAM 185 183 35 53
ZETIA 183 174 36 68
CLOPIDOGREL 178 170 37 26
HYDROCHLOROTHIAZIDE 176 175 38 10
ONGLYZA 175 163 39 153
ISOSORBIDE MONONITRATE ER 175 167 39 44
OMEPRAZOLE 173 173 41 3
SOLARAZE 163 150 42 157
DICYCLOMINE HCL 156 144 43 224
ADVAIR DISKUS 156 147 43 32
LOSARTAN-HYDROCHLOROTHIAZIDE 149 149 45 35
LOSARTAN POTASSIUM 147 146 46 14
TRAMADOL HCL-ACETAMINOPHEN 138 138 47 116
AZITHROMYCIN 138 133 47 42
PATANOL 133 121 49 158
CLONIDINE HCL 132 132 50 79
AVODART 130 117 51 107
DEXILANT 126 117 52 118
PRAVASTATIN SODIUM 126 126 52 23
LIDOCAINE 118 115 54 179
ESCITALOPRAM OXALATE 118 118 54 89
LANSOPRAZOLE 117 116 56 113
CLOTRIMAZOLE-BETAMETHASONE 116 112 57 94
VESICARE 116 116 57 210
RANEXA 115 115 59 167
ALCOHOL SWABS 114 113 60 115
TRIAMCINOLONE ACETONIDE 113 109 61 125
DONEPEZIL HCL 112 112 62 28
NAMENDA 109 101 63 47
BYSTOLIC 108 108 64 96
CLOTRIMAZOLE 108 101 64 296
GLYBURIDE-METFORMIN HCL 107 107 R 66 76
CICLOPIROX 105 94 67 279
MICARDIS 105 105 67 154
TEKTURNA 101 99 69 255
RANITIDINE HCL 100 93 70 36
NITROSTAT 100 100 70 205
TRAMADOL HCL 99 92 72 40
ENABLEX 98 98 73 284
LEXAPRO 91 91 74 193
TRICOR 88 88 75 148
FINASTERIDE 88 88 75 69
RAMIPRIL 88 66 75 50
COUMADIN 87 87 78 112
FAMOTIDINE 85 84 79 58
ZOVIRAX 85 82 79 313
GLYBURIDE 84 74 R 81 67
POTASSIUM CHLORIDE 84 84 81 34
ZENPEP 82 81 83 372
PROPRANOLOL HCL 81 81 84 199
ALLOPURINOL 81 74 84 41
DIGOXIN 80 67 86 56
GLIPIZIDE XL 80 80 86 83
CLOBETASOL PROPIONATE 80 72 86 130
POLYETHYLENE GLYCOL 3350 79 79 89 74
AMMONIUM LACTATE 78 77 90 91
AMITIZA 77 77 91 197
ACTONEL 76 76 92 134
JANUMET 75 75 93 77
METFORMIN HCL 73 71 94 7
PRANDIN 72 72 95 150
ACETAMINOPHEN-CODEINE 71 67 S3 96 127
ALENDRONATE SODIUM 67 67 97 18
ENALAPRIL MALEATE 66 66 98 22
MICARDIS HCT 65 65 99 180
VYTORIN 65 65 99 152
ACTOS 64 64 101 85
MAXALT 63 51 102 567
GLIMEPIRIDE 63 63 102 37
SERTRALINE HCL 63 63 102 30
FEXOFENADINE HCL 61 50 105 358
DOXAZOSIN MESYLATE 61 61 105 103
NIFEDIPINE ER 60 60 107 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 59 108 49
SILVER SULFADIAZINE 59 59 108 207
IBUPROFEN 58 58 110 72
SINGLE USE SWAB 58 58 110 108
CILOSTAZOL 57 57 112 206
BETAMETHASONE DIPROPIONATE 56 56 113 260
PRADAXA 56 56 113 192
NITROGLYCERIN PATCH 56 56 113 149
SPIRIVA 55 55 116 54
EXELON 54 54 117 162
LYRICA 54 54 117 133
EXFORGE 53 53 119 126
HYDRALAZINE HCL 52 52 120 73
COMBIVENT 51 51 121 156
DETROL LA 51 51 121 249
LEVOFLOXACIN 50 50 123 109
TOPROL XL 50 50 123 227
GABAPENTIN 50 50 123 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.